Lyra Therapeutics Inc (LYRA) — Financial Flexibility Index
Lyra Therapeutics Inc (LYRA) has a Financial Flexibility Index of -0.13x as of December 2025. Free cash flow of $-5.97 Million (operating CF $-6.07 Million minus capex $96.00K) represents 0% of total liabilities ($46.83 Million). Check asset allocation strategy of Lyra Therapeutics Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lyra Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Lyra Therapeutics Inc across 8 annual periods. See how liquid is Lyra Therapeutics Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Lyra Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Lyra Therapeutics Inc. For the full company profile including market capitalisation, see how much is Lyra Therapeutics Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.61x | $-28.74 Million | $-28.86 Million | $46.83 Million | ▲ +50.3% |
| 2024 | -1.24x | $-67.67 Million | $-70.01 Million | $54.75 Million | ▼ -5.6% |
| 2023 | -1.17x | $-62.26 Million | $-63.30 Million | $53.18 Million | ▲ +20.9% |
| 2022 | -1.48x | $-43.22 Million | $-43.38 Million | $29.21 Million | ▼ -35.5% |
| 2021 | -1.09x | $-22.43 Million | $-25.82 Million | $20.55 Million | ▲ +64.3% |
| 2020 | -3.06x | $-19.37 Million | $-21.14 Million | $6.34 Million | ▼ -72.3% |
| 2019 | -1.77x | $-13.54 Million | $-13.75 Million | $7.63 Million | ▼ -3457.6% |
| 2018 | -0.05x | $-6.60 Million | $-6.64 Million | $132.43 Million | — |